Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Aug 7, 2025
BEACON-IPF close out activities continue
Previously announced workforce and operational realignment largely complete
Phase 1 oncology trial on track to deliver additional data by the end of the year
NASDAQ:PLRX (11/28/2025, 11:09:15 AM)
1.6
+0.02 (+1.27%)
Find more stocks in the Stock Screener
